Na, J.-E.; Park, Y.-E.; Park, J.-H.; Kim, T.-O.; Lee, J.-Y.; Lee, J.-H.; Park, S.-B.; Lee, S.-B.; Hong, S.-M.
Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study. J. Pers. Med. 2024, 14, 1066.
https://doi.org/10.3390/jpm14101066
AMA Style
Na J-E, Park Y-E, Park J-H, Kim T-O, Lee J-Y, Lee J-H, Park S-B, Lee S-B, Hong S-M.
Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study. Journal of Personalized Medicine. 2024; 14(10):1066.
https://doi.org/10.3390/jpm14101066
Chicago/Turabian Style
Na, Ji-Eun, Yong-Eun Park, Jong-Ha Park, Tae-Oh Kim, Jong-Yoon Lee, Jong-Hoon Lee, Su-Bum Park, Seung-Bum Lee, and Seung-Min Hong.
2024. "Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study" Journal of Personalized Medicine 14, no. 10: 1066.
https://doi.org/10.3390/jpm14101066
APA Style
Na, J.-E., Park, Y.-E., Park, J.-H., Kim, T.-O., Lee, J.-Y., Lee, J.-H., Park, S.-B., Lee, S.-B., & Hong, S.-M.
(2024). Efficacy of Second-Line Biological Therapies in Moderate to Severe Ulcerative Colitis Patients with Prior Failure of Anti-Tumor Necrosis Factor Therapy: A Multi-Center Study. Journal of Personalized Medicine, 14(10), 1066.
https://doi.org/10.3390/jpm14101066
